A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells

[1]  Massimo Broggini,et al.  Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.

[2]  Hui Song,et al.  Wnt3a promotes epithelial–mesenchymal transition, migration, and proliferation of lens epithelial cells , 2012, Molecular vision.

[3]  Jun Zhu,et al.  Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. , 2012, Cellular signalling.

[4]  Y. Xin,et al.  Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells. , 2012, The international journal of biochemistry & cell biology.

[5]  M. Gleave,et al.  The importance of integrin‐linked kinase in the regulation of bladder cancer invasion , 2012, International journal of cancer.

[6]  H. Kuwano,et al.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma , 2011, British Journal of Cancer.

[7]  Hong-yan Li,et al.  Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells. , 2011, The international journal of biochemistry & cell biology.

[8]  J. Schlom,et al.  Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells , 2011, Experimental biology and medicine.

[9]  Jun Zhu,et al.  Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials , 2011, Molecular and Cellular Biochemistry.

[10]  G. Dekan,et al.  Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  Jingjing Wu,et al.  HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. , 2011, Cancer research.

[12]  M. Shibuya,et al.  Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. , 2010, Cancer research.

[13]  C. Ghigna,et al.  Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene , 2010, The Journal of cell biology.

[14]  A. Nekrasov,et al.  Structural Features of the Interfaces in Enzyme-Inhibitor Complexes , 2010, Journal of biomolecular structure & dynamics.

[15]  J. Dering,et al.  Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer , 2010, Breast Cancer Research and Treatment.

[16]  B. Czerniak,et al.  Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. , 2010, Urologic oncology.

[17]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[18]  Youhua Liu.  New insights into epithelial-mesenchymal transition in kidney fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.

[19]  Laikui Liu,et al.  Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome , 2010, Modern Pathology.

[20]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[21]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[22]  S. Dedhar,et al.  Integrin-linked kinase – essential roles in physiology and cancer biology , 2008, Journal of Cell Science.

[23]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[24]  Mahitosh Mandal,et al.  Epithelial to mesenchymal transition in head and neck squamous carcinoma , 2008, Cancer.

[25]  D. Huntsman,et al.  Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK) , 2008, Molecular Cancer Therapeutics.

[26]  Xiu-yun Cui,et al.  Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells. , 2005, The international journal of biochemistry & cell biology.

[27]  S. Dedhar,et al.  Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth , 2005, Oncogene.

[28]  R. Raines,et al.  Ribonuclease inhibitor as an intracellular sentry. , 2003, Nucleic acids research.

[29]  R. Shapiro,et al.  Cytoplasmic ribonuclease inhibitor. , 2001, Methods in enzymology.

[30]  B. Kobe,et al.  The leucine-rich repeat as a protein recognition motif. , 2001, Current opinion in structural biology.

[31]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[32]  J. McCubrey,et al.  The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). , 2011, Advances in enzyme regulation.

[33]  H. Nanjing.  Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas:correlation with the clinicopathological features and patient outcome , 2010 .

[34]  S. Dedhar,et al.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK , 2005, Nature Reviews Cancer.

[35]  M. Gleave,et al.  Regulation of tumor angiogenesis by integrin-linked kinase (ILK). , 2004, Cancer Cell.

[36]  Alberto Redaelli,et al.  The health economics of bladder cancer: a comprehensive review of the published literature. , 2003, PharmacoEconomics.